Font Size: a A A
Keyword [cardiovascular events]
Result: 161 - 180 | Page: 9 of 10
161. Efficacy Of The Treetment Of Emergent And Elective Percutaneous Coronary Intervention In Pationts With Acute ST-Segment Elevation Myocardial Infaction
162. Establishment Of CYP2C19 Gene Polymorphism Detection And Its Clinical Applications
163. The Impact Of ACVE And PPL With The Treatment Of Statin In Patients With AMI
164. Intermediate-term Clinical Outcomes Of Coronary Heart Disease Treated By Everolimus-eluting Stent Or Rapamycin-eluting Stent
165. New Progress In The Study And Treatment Of Coronary Artery Calcification
166. Clinic Value Of Different Antiplatelet Therapy Policies In Preventing And Treating Cardiovascular Events In Elderly Patients With Coronary Heart Disease
167. Plasma Soluble ST2 Level And Its Prognostic Value In Patients With Heart Failure With Preserved Ejection Fraction
168. Risk Of Major Adverse Cardiovascular Events In Patients With Metabolic Syndrome After Revascularization: A Meta-analysis Of Eighteen Cohorts With 18457 Patients
169. Study On Correlation Between Red Blood Cell Distribution Width And Cardiovascular Events And Mortality In Hemodialysis Patients
170. The Influences Of The CYP2C19 Gene Polymorphism And The Level Of MicroRNA～26a Expressed In Platelets Participates On Clopidogrel Resistance Of Patients Receiving PCI And Effects Of Different Therapeutic Methods On Patients With Clopidogrel Resistance
171. Macrophage Migration Inhibitory Factor As A Novel Biomarker For The Severity And Prognosis Of Coronary Heart Disease
172. The Clinical Evaluation Of 18F-fluoride PET/CT For Identification Of Unstable Atherosclerotic Plaques
173. Influence Of Endothelial Function And Prognostic Value Of Reactive Hyperemia Index For Cardiovascular Events In Aged People
174. The Impact Of Anxiety And Depression On PCI Patients And The Effectiveness Of Mindfulness-based Intervention
175. Research On The Relationship Of Serum Galectin-3 And Fibroblast Growth Factor 23 With Cardiovascular Risk In Patients With Chronic Kidney Disease
176. Effect Of Seasonal Adjustment Medication On Cardiovascular Events And The Plasma D-dimer Level
177. Clinical Evaluation Of The Relationship Between PCSK9 And The Development Of Coronary Heart Disease
178. Molecular Genetic And Clinical Studies Of Hypertrophic Cardiomyopathy
179. A Randomized, Double-blind, Controlled Study Of The Effects Of Qingxin Jieyu Recipe On Clinical Endpoints Of Stable Coronary Heart Disease
180. Association Of 24hours Urine Volume And Cardiovascular Events In Peritoneal Dialysis Patients
  <<First  <Prev  Next>  Last>>  Jump to